YouGene is a clinical genetic data marketplace founded in 2009. The company aims to establish the world's first marketplace where laboratories are financially incentivized to share valuable genetic biomarkers with other stakeholders. This innovative approach not only benefits clinicians and insurers who gain access to a comprehensive database of validated biomarkers but also compensates laboratories for their novel contributions. In addition, test developers can mitigate regulatory risk by utilizing a regulatory-compliant database. YouGene employs a patent-pending, micro-attribution royalty framework that encourages submission with income payments and trade secret protection. This platform effectively induces laboratories, clinicians, and insurers to participate in the marketplace, fostering collaboration and innovation in the field of genetic data. With its headquarters in the United States, YouGene presents an intriguing opportunity for venture capitalists seeking to support pioneering solutions in the healthcare and biotechnology industries. Watch this space for potential investment developments as YouGene continues to make strides in revolutionizing the utilization of genetic data.
There is no investment information
No recent news or press coverage available for YouGene.